Loss of Stag2 cooperates with EWS-FLI1 to transform murine Mesenchymal stem cells.
Marc El BeainoJiayong LiuAmanda R WasylishenRasoul PourebrahimAgata MigutBryan J BessellieuKe HuangPatrick P LinPublished in: BMC cancer (2020)
Loss of Stag2 has a synergistic effect with EWS-FLI1 in the production of sarcomas from murine MSCs, but the mechanism may not relate to increased proliferation or chromosomal instability. Primary murine MSCs are resistant to transformation, and the combination of p53 null mutation, EWS-FLI1, and Stag2 inhibition does not confer immediate conversion of MSCs to sarcomas. Irradiation is necessary in this model, suggesting that perturbations of other genes beside Stag2 and p53 are likely to be essential in the development of EWS-FLI1-driven sarcomas from MSCs.